Insider filing · TARS
Bryan Wahl
General Counsel
profile →
Tarsus Pharmaceuticals, Inc.
TARS · Healthcare · 35 filings in 24 months
ticker →
Bryan Wahl sold $464K of Tarsus Pharmaceuticals (TARS)
Executed Mar 18 2025, disclosed Mar 20 2025, 2 days later.
Value, as filed
$464K
9,686 sh across 3 lots
Executed
Mar 18 2025
the trade date, as filed
Disclosed
Mar 20 2025
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
BWBryan Wahl (General Counsel) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Tarsus Pharmaceuticals, Inc. (TARS). The largest single filing was $850K of TARS (12,440 sh across 3 lots, as filed), executed Mar 17.
The name
TARSHealthcare · Tarsus Pharmaceuticals, Inc., a commercial stage biopharmaceutical company, focuses on the development and commercialization of therapeutic…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Bryan Wahl in TARS
TARSSALE
Tarsus Pharmaceuticals, Inc.
$850K12,440 sh across 3 lots
Exec Mar 17
Filed Mar 19 · 5:30 PM ET